STOCKSCOPE

Ventia Services (ASX: VNT): A 15% Rally, but Is There More to Come?

Mark Elzayed

Mark Elzayed

CIO at Vestra Capital

Published:16 Oct 2026
Ventia Services (ASX: VNT): A 15% Rally, but Is There More to Come?

We've been following Ventia Services (ASX: VNT) for some time, and its almost 15% share price gain over the past six months has caught our attention. But what interests us most is that the infrastructure services group is growing earnings even as revenue declines. Could this be a sign of a stronger, more profitable business emerging beneath the surface?

Revenue is falling, but profits are rising

  • Revenue: $2.9 billion, down 4.7% in the first half of 2026.
  • Underlying EBITDA: $273.3 million, up 8.2%.
  • Underlying NPATA: $128.2 million, up 7.4%.
  • Work in hand: $21.1 billion, up 2.5% year on year.
  • Operating cash flow conversion: 93.8%.

Source: Ventia's investor reporting suite.

The real story is what's happening to margins

Ventia's revenue decline reflected a one-off change to its Defence services contract, partly offset by growth across its other three sectors. Meanwhile, its EBITDA margin improved to 9.4%, highlighting the benefits of operational efficiencies and a focus on higher-margin work.

We see this as the central investment question. If Ventia can keep lifting profitability without relying on strong revenue growth, earnings could prove more resilient than headline sales figures suggest. However, investors need to determine whether these gains are sustainable or reflect temporary benefits.

Its $21.1 billion work-in-hand balance, supported by seven material contract wins and renewals across Transport, Water and Defence, offers visibility over future activity. The challenge is converting that pipeline into profitable revenue while managing costs.

Cash returns are attractive, but execution matters

Ventia has increased its on-market share buyback programme to $300 million and raised its interim dividend by 9.8% to 11.76 cents per share, fully franked. These moves underline confidence in cash generation, although capital returns alone do not establish whether the shares are attractively valued.

A leadership transition adds another consideration, with CEO Dean Banks expected to depart in the fourth quarter of 2026.

Investor Insight: Can margins keep climbing?

We would watch whether Ventia sustains its 9.4% EBITDA margin while converting its substantial contract pipeline into earnings and cash. Continued margin strength and cash conversion would support the investment case. A reversal would suggest recent profit growth may be harder to repeat.

Why VNT remains on our radar

Our view is that Ventia deserves attention as a potential earnings-resilience story, rather than simply a revenue-growth play. The six-month share price gain suggests investors have already taken notice, making execution increasingly important. We would become more confident if the next results confirm sustained margins, reliable cash generation and profitable contract growth. The key question is whether operational improvement can continue to justify the market's growing interest.

Mark Elzayed

Mark Elzayed

(CIO at Vestra Capital)

Mark Elzayed is a prominent Australian financial executive and portfolio strategist with over a decade of hands-on capital markets experience. Having successfully managed over $100M+ in FUM across volatile economic cycles, Mark founded Vestra Capital to democratize institutional-grade quantitative strategies and privileged ASX deal flow for Australian investors.

DisclaimerInformation on Stockscope is general in nature and does not constitute financial product advice. It does not take into account your personal objectives, financial situation or needs. Seek independent advice from a qualified financial adviser before making an investment decision. Stockscope and its affiliates do not guarantee the accuracy or completeness of information published on this website. To the extent permitted by law, they accept no liability for any claim, loss or damage arising from its use or reliance on it. Stockscope and its associates may have commercial relationships with companies featured on this website, hold securities in those companies, or receive commissions in connection with capital raisings.

Continue Reading

ASX Weathers Wall Street's AI Rout, but Three Market Risks Are Becoming Harder to Ignore
Market Briefings
Market Briefings

ASX Weathers Wall Street's AI Rout, but Three Market Risks Are Becoming Harder to Ignore

Australian equities: what moved the ASX 200? Australian shares finished lower on Friday, 6 November, as the technology-led sell-off on Wall Street spread across global markets. The ASX 200...

Mark ElzayedMark Elzayed•
Epiminder (ASX: EPI) Expands FDA Clearance as $65 Million Cash Reserve Faces a Crucial Commercial Test
Biotech & Health
Biotech & Health

Epiminder (ASX: EPI) Expands FDA Clearance as $65 Million Cash Reserve Faces a Crucial Commercial Test

Epiminder Limited ASX: EPI has expanded the US market for its epilepsy monitoring technology following a significant regulatory clearance, strengthening its commercial prospects ahead of a p...

Danny AadDanny Aad•
Asara Resources (ASX: AS1) Hits 38m at 2.1g/t Gold: Could Sogosogoba Unlock Kada's Next Growth Phase?
Mining
Mining

Asara Resources (ASX: AS1) Hits 38m at 2.1g/t Gold: Could Sogosogoba Unlock Kada's Next Growth Phase?

A 38-metre gold intersection grading 2.1 grams per tonne has given Asara Resources Limited ASX: AS1 an encouraging exploration result beyond its established Massan deposit in Guinea. The dis...

Alison ElzayedAlison Elzayed•
Alvo Minerals (ASX: ALV) Expands Rare Earth Discovery Across 6.5km², but Can It Deliver Economic Value?
Mining
Mining

Alvo Minerals (ASX: ALV) Expands Rare Earth Discovery Across 6.5km², but Can It Deliver Economic Value?

Alvo Minerals Limited ASX: ALV has extended rare earth mineralisation approximately 2 kilometres beyond previously tested areas at its Boa Vista prospect in Brazil, strengthening the explora...

Alison ElzayedAlison Elzayed•
Avenira Limited (ASX: AEV) Raises $48.9 Million as Wonarah Phosphate Project Faces Its Biggest Test Yet
Mining
Mining

Avenira Limited (ASX: AEV) Raises $48.9 Million as Wonarah Phosphate Project Faces Its Biggest Test Yet

Avenira Limited ASX: AEV has reached a significant financing milestone, with its $48.9 million rights issue providing fresh capital to advance the Wonarah Phosphate Project in the Northern T...

Alison ElzayedAlison Elzayed•
Mayne Pharma Group (ASX: MYX) Unveils $55.5 Million Sale, but Can Its US Business Deliver Stronger Profits?
Biotech & Health
Biotech & Health

Mayne Pharma Group (ASX: MYX) Unveils $55.5 Million Sale, but Can Its US Business Deliver Stronger Profits?

Mayne Pharma Group Limited ASX: MYX is taking a decisive step towards becoming a US-focused pharmaceutical company, agreeing to sell its international operations for $55.5 million. The tran...

Danny AadDanny Aad•
Loading more stories...